In today’s recent session, 0.72 million shares of the Fate Therapeutics Inc (NASDAQ:FATE) have been traded, and its beta is 1.99. Most recently the company’s
Fate Therapeutics Inc (NASDAQ:FATE)’s traded shares stood at 1.03 million during the last session, with the company’s beta value hitting 1.98.The FATE share’s 52-week high
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
